Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranilast in CAPS Patients
NCT03923140Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2019
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tranilast in Cryopyrin-associated periodic syndromes (CAPS), sponsored by Peking Union Medical College Hospital. Primary endpoint: Auto-Inflammatory Diseases Activity Index at 6 months. Status: unknown.
02
Drugs
tranilast
03
Conditions
Cryopyrin-associated periodic syndromes (CAPS)
Beyond the preview
Go deeper on NCT03923140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03923140.